Dr. Carol Thiele, Head of the Cell and Molecular Biology Section in the Pediatric Oncology Branch, takes you into her lab where she researches the molecular mechanisms of neuroblastoma cells. Dr. Thiele studies whether these cells proliferate or differentiate in response to various compounds, a key factor for developing new therapeutic approaches to treat neuroblastoma. Watch and listen to Dr. Thiele's progress in discovering less toxic and more effective therapies for neuroblastoma patients.
A service of the National Cancer Institute
